Table 2 Characteristics of the participants of the FranSO study at baseline
Variable | EMS&P (n = 33) MV (95%-CI) | WPS (n = 33) MV (95%-CI) | CG (n = 34) MV (95%-CI) | P-value |
|---|---|---|---|---|
Age [years] | 77.1 (75.6 to 78.7) | 78.1 (76.3 to 80.0) | 76.9 (75.2 to 78.7) | .571 |
Body mass index [kg] | 26.2 (25.3 to 27.0) | 26.3 (25.4 to 27.1) | 26.0 (25.2 to 26.9) | .941 |
Lean body mass [kg/m2] a | 51.8 (49.9 to 53.6) | 52.1 (50.3 to 54.1) | 52.6 (50.5 to 54.8) | .805 |
Total body fat [%] a | 31.6 (30.2 to 32.8) | 31.4 (30.0 to 32.5) | 31.4 (30.1 to 32.7) | .967 |
Gait velocity [m/s] | 1.26 (1.19 to 1.33) | 1.24 (1.18 to 1.30) | 1.27 (1.21 to 1.33) | .857 |
Handgrip-strength [kg] | 33.8 (31.0 to 36.6) | 33.3 (31.2 to 35.4) | 34.4 (32.1 to 36.6) | .814 |
Number of diseases [n] b | 2.71 (2.38 to 3.05) | 2.78 (2.36 to 3.16) | 2.56 (2.16 to 2.96) | .584 |
Number of medications [n] | 3.31 (2.80 to 3.83) | 3.49 (3.02 to 3.95) | 3.40 (2.91 to 3.91) | .801 |
LLFDI [Index]c | 1.52 (1.32 to 1.71) | 1.58 (1.39 to 1.76) | 1.53 (1.35 to 1.70) | .193 |
Physical activity [Index]d | 4.35 (3.84 to 4.87) | 4.16 (3.65 to 4.66) | 4.68 (4.10 to 5.25) | .371 |
Training volume [min/week] | 36 (24 to 48) | 35 (24 to 46) | 40 (28 to 51) | .810 |
Energy intake [kJ/d]e | 8967 (8385 to 9590) | 8670 (7823 to 9521) | 9516 (8512 to 10,488) | . 352 |
Protein intake [g/kg/d] e | 1.17 (1.06 to 1.29) | 1.01 (0.90 to 1.13) | 1.21 (1.06 to 1.37) | .066 |
Total cholesterol [mg/dl] | 215 (199 to 231) | 205 (194 to 217) | 201 (182 to 220) | .422 |
HDL-cholesterol [mg/dl] | 53.3 (49.7 to 56.9) | 52.3 (48.4 to 56.2) | 54.0 (48.5 to 59.6) | .874 |
LDL-Cholesterol [mg/dl] | 146 (132 to 159) | 137 (127 to 147) | 133 (119 to 147) | .320 |